Literature DB >> 21492600

Suboccipital approach for primitive trigeminal artery obliteration associated with cavernous aneurysm.

Tetsuyoshi Horiuchi1, Yosuke Hara, Tetsuo Sasaki, Hisashi Nagashima, Kazuhiro Hongo.   

Abstract

OBJECTIVE: A 63-year-old woman presented with diplopia resulting from abducens paralysis. Examination revealed a giant cavernous aneurysm supplied by the internal carotid artery (ICA) and primitive trigeminal artery (PTA) via the vertebrobasilar system.
METHODS: After evaluation of balloon test occlusion (BTO) at the distal side of the PTA origin, the aneurysm was treated with PTA obliteration through the suboccipital route in the lateral position followed by cervical carotid ligation with superficial temporal artery-to-middle cerebral artery anastomosis in the supine position.
RESULTS: The aneurysm showed marked shrinkage after the surgery.
CONCLUSION: PTA obliteration through the retrosigmoid opening is a therapeutic surgical option in a patient with a cavernous aneurysm supplied by the PTA.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21492600     DOI: 10.1016/j.wneu.2010.06.029

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

Review 1.  The persistent trigeminal artery: development, imaging anatomy, variants, and associated vascular pathologies.

Authors:  Stephan Meckel; Bjoern Spittau; William McAuliffe
Journal:  Neuroradiology       Date:  2011-12-16       Impact factor: 2.804

2.  Ruptured cerebral aneurysm associated with a persistent primitive trigeminal artery variant.

Authors:  Takahiro Yamamoto; Yu Hasegawa; Yuki Ohmori; Takayuki Kawano; Yutaka Kai; Motohiro Morioka; Jun-Ichi Kuratsu
Journal:  Surg Neurol Int       Date:  2011-09-17

3.  Rescue revision techniques for end-to-side anastomosis: Technical note.

Authors:  Tetsuyoshi Horiuchi; Keiji Tsutsumi; Takatoshi Hasegawa; Kazuhiro Hongo
Journal:  Surg Neurol Int       Date:  2014-06-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.